Landscape version of the Flipboard logo
    Newsletters
  • Sign up
  • Log in

STAT

Discover in-depth analysis of biopharma and the life sciences. Reporting from the frontiers of health & medicine. Sign up for any of our 10 free newsletters here: http://statnews.com/signup

  • 29 Magazines
  • 11 Storyboards
  • 4k Followers

Storyboards

Go to feed

  • American Science, Shattered

  • Embedded Bias: The struggle over removing race from clinical algorithms

  • How doctors coerce sickle cell patients into unwanted sterilizations

  • STAT Breakthrough Summit East

  • The War On Recovery

  • 2024 STATUS List - The Leaders Shaping The Headlines

  • Investigating UnitedHealth Group

  • STAT at JPM 2024

  • 2023 STAT Summit

  • 2023 STATUS List: The definitive list of leaders in life sciences

  • Death Sentence: Prisoners are dying from hepatitis C

Magazines

  • Top Stories

    By STAT

  • Bird Flu Watch: A Chronicle of Contagion

    By STAT

  • climate change & our health

    By STAT

  • STAT Events

    By STAT

  • FDA news

    By STAT

  • STAT Video

    By STAT

  • Women's Health

    By STAT

  • Health stories & Societal Impact

    By STAT

  • CRISPR & Gene editing

    By STAT

  • STAT ebooks

    By STAT

  • Medicare Advantage 101

    By STAT

  • STAT's deep-dive reports

    By STAT

  • Funding the future of health and medicine

    By STAT

  • Vaccine frontiers: Exploring Advances in Immunization

    By STAT

  • Artificial intelligence in health care and biotech

    By STAT

  • The tangled web of drug pricing

    By STAT

  • Post-Roe America

    By STAT

  • STAT reports from the frontlines of addiction

    By STAT

  • Mental Health & Depression

    By STAT

  • Developments in medicine

    By STAT

  • In the lab: stories of clinical research

    By STAT

  • STAT makes sense of cancer research

    By STAT

  • The top headlines in pharma

    By STAT

  • What’s on deck in health tech

    By STAT

  • Health policy news, straight from Washington

    By STAT

  • The business of biotech

    By STAT

  • COVID ISN'T OVER

    By STAT

  • The obesity revolution

    By STAT

  • STAT's HOMEPAGE

    By STAT

Followers

Flips

  • STAT
    flipped into STAT's HOMEPAGE
    1 hour ago

    Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk

    STAT - Elaine Chen

    Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it up for fierce competition against Novo Nordisk’s …

  • STAT
    flipped into The business of biotech
    3 hours ago

    Insilico Medicine CEO on how best to use AI in drug development

    STAT - Brittany Trang

    They remind you to not talk during the movie, but when I saw “Project Hail Mary” last week, I was so alarmed that Ryan Gosling placed two Eppendorf …

  • STAT
    flipped into The business of biotech
    3 hours ago

    Novo's subscription model raises questions about pharma-telehealth tie-ups

    STAT - Elaine Chen

    Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re …

  • STAT
    flipped into The top headlines in pharma
    4 hours ago

    Pharmalittle: We're reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more

    STAT - Ed Silverman

    Hello, everyone, and welcome to the middle of the week. Congratulations on making it this far. It is an accomplishment, after all. The next step is …

  • STAT
    flipped into STAT's HOMEPAGE
    5 hours ago

    Supreme Court rules against conversion therapy ban

    STAT - Theresa Gaffney

    Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. As you hopefully …

  • STAT
    flipped into STAT's HOMEPAGE
    8 hours ago

    The biotech scorecard for the second quarter: 23 stock-moving events to watch

    STAT - Adam Feuerstein

    Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second quarter: Abivax: Maintenance outcomes from the …

  • STAT
    flipped into STAT's HOMEPAGE
    8 hours ago

    Can a psychedelic 'coach' make ketamine therapy even more effective?

    STAT - O. Rose Broderick

    Ketamine treatment clinics have proliferated following the Food and Drug Administration’s approval of the drug as a remedy for acute depression in …

  • STAT
    flipped into STAT's HOMEPAGE
    8 hours ago

    Medical marijuana should not be recommended for PTSD, anxiety, or depression

    STAT - Kevin A. Sabet

    Thirty-eight states plus the District of Columbia allow practitioners to recommend medical marijuana for post-traumatic stress disorder. But what if …

  • STAT
    flipped into STAT's HOMEPAGE
    8 hours ago

    Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene

    STAT - Diego Schaps

    The Centers for Medicare and Medicaid Services has decided to include ostomy supplies in its competitive bidding program (CBP), limiting supplier …

  • STAT
    flipped into STAT's HOMEPAGE
    8 hours ago

    Why an ovary syndrome may get a new name: Men seem to have PCOS, too

    STAT - Annalisa Merelli

    Few things will give a man as much of an insight into the female body as growing up with sisters. Painful, irregular periods, body hair, skin …

  • STAT
    flipped into Health policy news, straight from Washington
    8 hours ago

    NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback

    STAT - Anil Oza

    It is perhaps not surprising that the director of the National Institutes of Health would invoke the name of a man revered by scientists as the …

  • STAT
    flipped into Health policy news, straight from Washington
    23 hours ago

    The HSA industry makes its MAHA pitch

    STAT - John Wilkerson

    You got your MAGA, then you got your MAHA. Read on to learn about GAHA. And send news tips to [email protected] or John_Wilkerson.07 on Signal. MAHA’s …

  • Log in
  • Newsletters
  • About Us
  • Blog
  • Tools
  • Publishers
  • Help
  • Terms
  • Privacy Policy
  • Sitemap
© 2026 Flipboard